Angana Biswas

Employment

• Weill Cornell Medicine Fulbright Visiting Researcher
  2019 - 2020
• Indian Institute of Technology Kharagpur PhD Research Scholar
  2015 - Present

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (13)

• Therapeutic targeting of RBPJ, an upstream regulator of ETV6 gene, abrogates ETV6-NTRK3 fusion gene transformations in glioblastoma
  Cancer Letters 2022 DOI: 10.1016/j.canlet.2022.215811
  +Save
• An insight into the ubiquitin-proteasomal axis and related therapeutic approaches towards central nervous system malignancies
  Biochimica et Biophysica Acta - Reviews on Cancer 2022 DOI: 10.1016/j.bbcan.2022.188734
  +Save
• TGF-β1 induced autophagy in cancer associated fibroblasts during hypoxia contributes EMT and glycolysis via MCT4 upregulation
  Experimental Cell Research 2022 DOI: 10.1016/j.yexcr.2022.113195
  +Save
• ETV6 gene aberrations in non-haematological malignancies: A review highlighting ETV6 associated fusion genes in solid tumors
  Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2020 DOI: 10.1016/j.bbcan.2020.188389
  +Save
• Lumefantrine, an antimalarial drug, reverses radiation and temozolomide resistance in glioblastoma.
  Proceedings of the National Academy of Sciences of the United States of America 2020 DOI: 10.1073/pnas.1921531117
  +Save
• Transcriptional regulation of HSPB1 by Friend leukemia integration-1 factor modulates radiation and temozolomide resistance in glioblastoma
  Oncotarget 2020
  +Save
• Delineation of crosstalk between HSP27 and MMP-2/MMP-9: A synergistic therapeutic avenue for glioblastoma management
  Biochimica et Biophysica Acta - General Subjects 2019 DOI: 10.1016/j.bbagen.2019.04.015
  +Save
• Push-Pull Stilbene: Visible Light Activated Photoremovable Protecting Group for Alcohols and Carboxylic Acids with Fluorescence Reporting Employed for Drug Delivery
  Organic Letters 2019 DOI: 10.1021/acs.orglett.9b00124
  +Save
• Targeting NFE2L2, a transcription factor upstream of MMP-2: A potential therapeutic strategy for temozolomide resistant glioblastoma
  Biochemical Pharmacology 2019 DOI: 10.1016/j.bcp.2019.03.025
  +Save
• Targeting ECM via stress associated regulation: A potential therapeutic avenue for overcoming temozolamide resistance in glioblastoma
  New Biotechnology 2018 DOI: 10.1016/j.nbt.2018.05.1112
  +Save